hiPSCs were seeded into 10-cm tissue culture plates and then allowed to grow for ~4 days until the cells became ~70% confluent. CMs were differentiated from iPSCs as previously described (79 (link)) [protocol originally adapted from Lian et al. (35 (link))]. Media were changed to RPMI 1640 + B27 + ascorbic acid (RPMI/B27/AA) containing the GSK3 inhibitor CHIR99021 (Selleck Chemicals) (6 μM) on day 0 of CM differentiation. On day 2 of differentiation, media were changed to RPMI/B27/AA containing the Wnt antagonist IWP-4 (Reprocell) (5 μM). On day 4 of differentiation, media were changed to fresh RPMI/B27/AA, and on day 7 of differentiation, basal media were changed to RPMI/B27 + insulin (10 μg/ml), with media subsequently changed every 2 to 3 days with RPMI/B27/insulin. Beating of CMs was usually observed between days 7 and 9 of differentiation. CMs were dissociated using the STEMdiff Cardiomyocyte Dissociation Kit (StemCell Technologies) and replated onto Geltrex-coated plates for further assay.